Autonomix Medical, INC. 8-K Filing
Ticker: AMIX · Form: 8-K · Filed: Nov 3, 2025 · CIK: 1617867
| Field | Detail |
|---|---|
| Company | Autonomix Medical, INC. (AMIX) |
| Form Type | 8-K |
| Filed Date | Nov 3, 2025 |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Autonomix Medical, INC. (ticker: AMIX) to the SEC on Nov 3, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (h Registered Common Stock , par value $0.001 per share AMIX The Nasdaq Stock Mark).
How long is this filing?
Autonomix Medical, INC.'s 8-K filing is 3 pages with approximately 835 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 835 words · 3 min read · ~3 pages · Grade level 10.7 · Accepted 2025-11-03 17:00:20
Key Financial Figures
- $0.001 — h Registered Common Stock , par value $0.001 per share AMIX The Nasdaq Stock Mark
Filing Documents
- amix20251030_8k.htm (8-K) — 44KB
- ex_880888.htm (EX-10.1) — 90KB
- logo.jpg (GRAPHIC) — 2KB
- 0001437749-25-032798.txt ( ) — 295KB
- amix-20251030.xsd (EX-101.SCH) — 3KB
- amix-20251030_def.xml (EX-101.DEF) — 12KB
- amix-20251030_lab.xml (EX-101.LAB) — 16KB
- amix-20251030_pre.xml (EX-101.PRE) — 12KB
- amix20251030_8k_htm.xml (XML) — 3KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. On October 30, 2025, Autonomix Medical, Inc. (the "Company") held its annual meeting of stockholders (the "Annual Meeting"). The number of shares of common stock that voted on matters presented at the Annual Meeting was 2,871,639, representing approximately 48% of the 5,941,992 shares common stock outstanding as of the September 8, 2025, the record date for the Annual Meeting (the "Record Date"), which represented a quorum to transact business at the Annual Meeting. Each director nominee was elected and each other matter submitted to a vote of the Company's stockholders at the Annual Meeting, as described below, was approved by the requisite vote of the Company's stockholders. The final voting results for each of the proposals submitted to a vote of the stockholders of the Company at the Annual Meeting are set forth below. The proposals are described in detail in the Company's Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission (the "SEC") on September 12, 2025 (the "Proxy Statement") and are incorporated herein by reference. Proposal 1. To elect five Board nominees to the Board of Directors of the Company, each to serve until the 2026 annual meeting of stockholders of the Company or until such person's successor is qualified and elected. Nominee Votes For Votes Withheld Broker Non-Votes Walter V. Klemp 1,236,672 43,026 1,591,941 Lori Bisson 1,228,794 50,904 1,591,941 Jonathan P. Foster 1,237,080 42,618 1,591,941 David Robins 1,195,185 84,513 1,591,941 Christopher Capelli 1,200,812 78,886 1,591,941 Proposal 2. To ratify the appointment of Forvis Mazars, LLP as the Company's independent registered public accounting firm for the year ending March 31, 2026. Votes For Votes Against Abstain Broker Non-Votes 2,609,156 91,309 171,174 0 Proposal 3. To approve an amendment to the Company's amended and restated certificate of incorporati
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits No. Description 10.1 Amended and Restated 2023 Equity Incentive Plan 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AUTONOMIX MEDICAL, INC. By: /s/ Trent Smith Trent Smith Chief Financial Officer Dated: November 3, 2025